El proper 8 d'octubre a les 12 h l'Aula Alsina i Bofill del Campus Clínic acollirà un nou seminari del Cicle Continuat de Conferències de la Facultat de Medicina i Ciències de la Salut. 

El seminari titulat "Preventive approaches and new technologies –future directions for the treatment of neuropsychiatric disorders” i serà a càrrec de la Dra. Nadine Bernhardt, Department of Psychiatry and Psychotherapy, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany, l'encarregat d'aquesta xerrada és el Dr. Albert Giralt.

Aquest seminari s'adreça a tot el PDI de la Facultat de Medicina i Ciències de la Salut i als centres de recerca de Barcelona i no cal inscripció prèvia per assistir-hi.

A continuació, una breu sinopsi dels temes que abordarà el Dra. Bernhardt durant al sessió:

Neuropsychiatric disorders such as affective disorders, schizophrenia and substance use disorders are characterised by marked disturbances of cognition, emotion and behaviour. They affect more than one in six people worldwide, with enormous individual and economic consequences. State-of-the-art treatment considers a combination of medications, cognitive therapies and social support. However, up to 60% of patients do not respond to these measures, and even with successful initial treatment, up to 80% of patients relapse. The talk will highlight the current concepts of the developmental and lifelong course of neuropsychiatric symptoms. It will pinpoint critical periods of profound brain (re)organisation associated with increased vulnerability to disorder manifestation. However, these periods also offer significant opportunities for interventions aimed at stopping or even preventing disruptive symptoms. Proof of concept data will be presented on preventive treatment strategies including electrical brain stimulation and pharmacological approaches during i) perinatal development and ii) adolescence in animal models of schizophrenia and autism. It will also outline our vision and evidence for a novel line of medical treatments based on multimodal neuroprosthetics that can have an impact on the most severe refractory cases.

No us perdeu aquest interessant seminari, recordeu no cal inscripció prèvia!